BDBM50219913 6-(4-((phenethylamino)methyl)phenoxy)pyridine-3-sulfonamide::CHEMBL238281

SMILES: NS(=O)(=O)c1ccc(Oc2ccc(CNCCc3ccccc3)cc2)nc1

InChI Key: InChIKey=IHBJOGHZHLNOBK-UHFFFAOYSA-N

Data: 3 KI

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 50219913   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Mu-type opioid receptor (Homo sapiens (Human))	BDBM50219913 (6-(4-((phenethylamino)methyl)phenoxy)pyridine-3-su...) Show SMILES NS(=O)(=O)c1ccc(Oc2ccc(CNCCc3ccccc3)cc2)nc1 Show InChI InChI=1S/C20H21N3O3S/c21-27(24,25)19-10-11-20(23-15-19)26-18-8-6-17(7-9-18)14-22-13-12-16-4-2-1-3-5-16/h1-11,15,22H,12-14H2,(H2,21,24,25)	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem	Article PubMed	>2.50E+3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Lilly Research Laboratories Curated by ChEMBL					Assay Description Antagonist activity at human mu opioid receptor expressed in CHO cells by [35S]GTP-gamma-S binding assay				Bioorg Med Chem Lett 17: 5349-52 (2007) Article DOI: 10.1016/j.bmcl.2007.08.008 BindingDB Entry DOI: 10.7270/Q2668CX7
					More data for this Ligand-Target Pair
Delta-type opioid receptor (Homo sapiens (Human))	BDBM50219913 (6-(4-((phenethylamino)methyl)phenoxy)pyridine-3-su...) Show SMILES NS(=O)(=O)c1ccc(Oc2ccc(CNCCc3ccccc3)cc2)nc1 Show InChI InChI=1S/C20H21N3O3S/c21-27(24,25)19-10-11-20(23-15-19)26-18-8-6-17(7-9-18)14-22-13-12-16-4-2-1-3-5-16/h1-11,15,22H,12-14H2,(H2,21,24,25)	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem	Article PubMed	>5.00E+3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Lilly Research Laboratories Curated by ChEMBL					Assay Description Displacement of [3H]bremazocine from human delta opioid receptor expressed in CHO cells in presence of high sodium by SPA				Bioorg Med Chem Lett 17: 5349-52 (2007) Article DOI: 10.1016/j.bmcl.2007.08.008 BindingDB Entry DOI: 10.7270/Q2668CX7
					More data for this Ligand-Target Pair
Kappa-type opioid receptor (Homo sapiens (Human))	BDBM50219913 (6-(4-((phenethylamino)methyl)phenoxy)pyridine-3-su...) Show SMILES NS(=O)(=O)c1ccc(Oc2ccc(CNCCc3ccccc3)cc2)nc1 Show InChI InChI=1S/C20H21N3O3S/c21-27(24,25)19-10-11-20(23-15-19)26-18-8-6-17(7-9-18)14-22-13-12-16-4-2-1-3-5-16/h1-11,15,22H,12-14H2,(H2,21,24,25)	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem	Article PubMed	>5.00E+3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Lilly Research Laboratories Curated by ChEMBL					Assay Description Displacement of [3H]diprenorphine from human kappa opioid receptor expressed in CHO cells in presence of high sodium by SPA				Bioorg Med Chem Lett 17: 5349-52 (2007) Article DOI: 10.1016/j.bmcl.2007.08.008 BindingDB Entry DOI: 10.7270/Q2668CX7
					More data for this Ligand-Target Pair